Effect of Nationwide Reimbursement of Sensor-Augmented Pump (SAP) Therapy in a Paediatric Type 1 Diabetes (T1D) Population on HbA1c, Hypoglycaemia, and Quality of Life (QoL) According to Age Groups in the RESCUE-Paediatrics Study

Francesca De Ridder, Seppe Jacobs, Sara Charleer, Pieter Gillard, Kristina Casteels, Sara Van Aken, Inge Gies, Guy Massa, Philippe A. Lysy, Karl Logghe, Marie-Christine Lebrethon, Sylvia Depoorter, Kristien J. Ledeganck, Christophe De Block, Marieke Den Brinker

Research output: Contribution to journalMeeting abstract (Journal)

Original languageEnglish
Article number1367-P
Issue numberS1
Publication statusPublished - 1 Jun 2019
EventADA: the 79th Scientific Sessions of the American Diabetes Association - San Francisco, United States
Duration: 7 Jun 201911 Jun 2019


  • Sensor-Augmented Pump
  • Type 1 Diabetes
  • HbA1c
  • Hypoglycaemia
  • Quality of Life
  • RESCUE-Paediatrics Study

Cite this